Efficacy and Tolerability of Riluzole in Treatment Resistant Depression

Conditions

Depression

What is the purpose of this trial?

This study aims to examine the antidepressant efficacy of riluzole, employing a randomized, double-blind, placebo-controlled, adjunctive trial in treatment-resistant major depressive disorder (TRD).



Participation Guidelines

Age:
18 Years - 65 Years
Gender:
Both

Click here for detailed information about who can participate in this trial.


Sponsor:
Yale University
Dates:
June 2011
Last Updated:
January 15, 2014
Study HIC#:

Clinicaltrials.gov ID: NCT01204918